{"id":"W4410085374","doi":"10.1016/j.euo.2025.04.012","title":"Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE Trial","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Janssen Research and Development; Johnson and Johnson","keywords":"Abiraterone acetate; Medicine; Prednisone; Prostate cancer; Abiraterone; Oncology; Castration; Internal medicine; Urology; Cancer; Androgen deprivation therapy; Hormone; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005468839,0.0009046795,0.001560011,0.0002680994,0.0002409062,0.001111718,0.0006362076,0.0006699759,0.004440038],"category_scores_gemma":[0.003961871,0.0003076961,0.003518813,0.0003772776,0.0004294149,0.0007272969,0.0004806508,0.002145039,0.0005395385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005417502,"about_ca_system_score_gemma":0.001489817,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000402321,"about_ca_topic_score_gemma":0.00122725,"domain_scores_codex":[0.9983029,0.001291945,0.0000647741,0.0001281885,0.0001169853,0.00009520912],"domain_scores_gemma":[0.9981071,0.0006018049,0.0006277425,0.0002255306,0.0001045311,0.0003331735],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9414358,0.002407706,0.006001775,0.0008659109,0.006397267,0.00005631345,0.00005276651,0.001954356,0.002539817,0.0002363331,0.002611726,0.03544035],"study_design_scores_gemma":[0.8362289,0.1019017,0.03775883,0.0003200434,0.01182992,0.000429044,0.00006526396,0.002665972,0.001623842,0.001562123,0.005555548,0.00005867825],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9678965,0.01825774,0.001676669,0.001442463,0.0004383463,0.001918769,0.004397061,0.000151399,0.00382115],"genre_scores_gemma":[0.9859824,0.003347062,0.001720426,0.0007557729,0.0003936263,0.001389525,0.004640262,0.00003349539,0.001737425],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005468839,"threshold_uncertainty_score":0.02892238,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08226572202178561,"score_gpt":0.4067053165190906,"score_spread":0.324439594497305,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}